id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-352302-are8vvhh	Hartman, W.	Hospitalized COVID-19 patients treated with Convalescent Plasma in a mid-size city in the midwest	2020-06-22		.txt	text/plain	3138	189	54	Methods Hospitalized COVID-19 patients categorized as having Severe or Life-Threatening disease according to the Mayo Clinic Emergency Access Protocol were screened, consented, and treated with convalescent plasma collected from local donors recovered from COVID-19 infection. Hospitalized COVID-19 patients categorized as having Severe or Life-Threatening disease according to the Mayo Clinic Emergency Access Protocol were screened, consented, and treated with convalescent plasma collected from local donors recovered from COVID-19 infection. A recent cohort study by Liu and colleagues of 39 cases and 156 matched controls from Mount Sinai hospital in New York City reported a 12.8% mortality rate among patients with severe or worse disease who received convalescent plasma, and significantly better outcomes among patients transfused prior to mechanical ventilation. . https://doi.org/10.1101/2020.06.19.20135830 doi: medRxiv preprint Figure 1 Legend: Inpatient respiratory support type by hospital day among COVID-19 patients with life-threatening disease receiving convalescent plasma (n = 15).	./cache/cord-352302-are8vvhh.txt	./txt/cord-352302-are8vvhh.txt